Its maker, Amersham Biosciences , a division of Amersham Plc. (nyse: AHM - news - people ) of the U.K., claims the IN Cell machine will cut years off the drug-discovery process.
Equipped with a mobile processor that combines a chipset, a processor, and graphics smarts, Hoff demonstrated lush visuals on a machine that will have a cut-rate price.